| Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges E Durinikova, K Buzo, S Arena Journal of Experimental & Clinical Cancer Research 40 (1), 185, 2021 | 27 | 2021 |
| Targeting the DNA damage response pathways and replication stress in colorectal cancer E Durinikova, NM Reilly, K Buzo, E Mariella, R Chilà, A Lorenzato, ... Clinical Cancer Research 28 (17), 3874-3889, 2022 | 20 | 2022 |
| Empowering clinical decision making in oligometastatic colorectal cancer: the potential role of drug screening of patient-derived organoids G Mauri, E Durinikova, A Amatu, F Tosi, A Cassingena, F Rizzetto, K Buzo, ... JCO Precision Oncology 5, 1192-1199, 2021 | 7 | 2021 |
| PHYTOPLASMAS DETECTION EFFECTIVENESS BASED ON SYMPTOMATOLOGY, DAPI STAINING AND SPECIFIC PCR AT PLUM PLANT MATERIAL OF DIFFERENT CATEGORIES D Mero, A Bacu, K Buzo European Journal of Biotechnology and Genetic Engineering Vol 3 (1), 2016 | 1 | 2016 |
| Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer E Mariella, G Grasso, M Miotto, K Buzo, NM Reilly, P Andrei, PP Vitiello, ... Molecular Oncology, 2024 | | 2024 |
